Acceleris Shortlisted for The British Private Equity Awards

Acceleris Shortlisted for The British Private Equity Awards

Private Equity Awards

 

Seneca Partners sister company, Acceleris Capital, has been nominated for the Unquote British Private Equity Awards 2015 for the company’s work with investee company Redx Pharma.

Unquote readers and industry professionals now have the chance to have their say and vote for which firms they believe should be recognised. The poll takes place via a secure online system containing a short summary of shortlisted candidates’ successes.

Cast your votes here

Acceleris has assisted Redx Pharma and it’s predecessor through numerous funding rounds to the value of £13m under the Enterprise Investment Scheme (before the £15m IPO raise) as well as maintaining a position on the board of the company and acting as company secretary. This relationship culminated in the companies admission to the AIM market in March 2015 at a market cap of £55.2m.

Redx Pharma plc has been taken from start-up to a successful listing by Acceleris Capital and the company is now regarded as one of the leading biotechnology firms in Europe.

Redx has already established a portfolio of 13 proprietary (patent-obtected) drug programs and has been named as one of the Times Top 10 disrupters to watch since admission.

150713_George_Osborne_with_Redx_management@2x

Following a recent visit by Chancellor George Osborne, the company has announced a further collaboration deal with Horizon Group plc and the share price has maintained a higher figure than on admission.

  • Voting closes this Thursday (September 10th)
  • Acceleris is nominated for Category 12: Venture Exit

Important information

This information is of a general nature and does not constitute an offer to provide services.

The opinions and conclusions given here are those of Seneca Partners and are subject to change without notice.

The value of investments and/or any income arising from them may fluctuate.

Past performance is not necessarily a guide to future performance.

Important notice

The products and services shown on this website place capital at risk. Investors may receive less in returns than they have invested. Investments may not allow for capital to be withdrawn on demand. If an investment provides tax relief then this relief is subject to change and is dependant on personal circumstances. Any reference to past performance or forecasted performance is not a reliable indicator of future performance.

Seneca Partners recommends that any investor seeks specialised financial and/or tax advice before investing. Seneca Partners does not provide advice and the information on this website, including but not limited to news, should not be construed as such.

Please confirm that you understand this warning and wish to proceed.